Veterinary Sciencenpj Vaccines
M2e nanovaccines supplemented with recombinant hemagglutinin protect chickens against heterologous HPAI H5N1 challenge
C. Calzas, T. N. Alkie, et al.
This research by Cynthia Calzas and colleagues presents a groundbreaking approach to protecting chickens from the avian influenza HPAI H5N1 by combining nanoparticles with M2e repeats and an HA1 vaccine. The results showcase complete protection against disease and reduced environmental shedding, paving the way for innovative influenza control strategies.
Related Publications
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
Medicine and Health
A single dose of recombinant VSV-ΔG-spike vaccine provides protection against SARS-CoV-2 challenge
Y. Yahalom-ronen, H. Tamir, et al.
Medicine and Health
A randomized controlled trial of heterologous ChAdOx1 nCoV-19 and recombinant subunit vaccine MVC-COV1901 against COVID-19
C. Chen, L. Yang, et al.
Medicine and Health
Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts
R. Kundu, J. S. Narean, et al.
Biology
Immune Response to Vaccination against COVID-19 at Different Second-Dose Intervals and Their Associations with Metabolic Parameters
Ł. Szczerbiński, M. A. Okruszko, et al.
